A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC.
Saved in:
| Title: | A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC. |
|---|---|
| Authors: | Burcher K; Duke Cancer Institute, Durham, NC 27710, USA., Karukonda P; Duke Cancer Institute, Durham, NC 27710, USA., Kelsey C; Duke Cancer Institute, Durham, NC 27710, USA., Mullikin T; Duke Cancer Institute, Durham, NC 27710, USA., Antonia SJ; Duke Cancer Institute, Durham, NC 27710, USA., Oduah EI; Duke Cancer Institute, Durham, NC 27710, USA. |
| Source: | Cancers [Cancers (Basel)] 2025 May 30; Vol. 17 (11). Date of Electronic Publication: 2025 May 30. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40507315 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Burcher+K%22">Burcher K</searchLink>; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Karukonda+P%22">Karukonda P</searchLink>; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Kelsey+C%22">Kelsey C</searchLink>; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Mullikin+T%22">Mullikin T</searchLink>; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Antonia+SJ%22">Antonia SJ</searchLink>; Duke Cancer Institute, Durham, NC 27710, USA.<br /><searchLink fieldCode="AU" term="%22Oduah+EI%22">Oduah EI</searchLink>; Duke Cancer Institute, Durham, NC 27710, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2025 May 30; Vol. 17 (11). <i>Date of Electronic Publication: </i>2025 May 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40507315 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/cancers17111829 Languages: – Code: eng Text: English Titles: – TitleFull: A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burcher K – PersonEntity: Name: NameFull: Karukonda P – PersonEntity: Name: NameFull: Kelsey C – PersonEntity: Name: NameFull: Mullikin T – PersonEntity: Name: NameFull: Antonia SJ – PersonEntity: Name: NameFull: Oduah EI IsPartOfRelationships: – BibEntity: Dates: – D: 30 M: 05 Text: 2025 May 30 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2072-6694 Numbering: – Type: volume Value: 17 – Type: issue Value: 11 Titles: – TitleFull: Cancers Type: main |
| ResultId | 1 |
